Old Web
English
Sign In
Acemap
>
Paper
>
Combination immunotherapy with anti-CD38 and ex vivo stimulated aß t-cell depleted pbmcs for multiple myeloma
Combination immunotherapy with anti-CD38 and ex vivo stimulated aß t-cell depleted pbmcs for multiple myeloma
2021
A. Pennati
A. Quamine
Kirsti L. Walker
C. Hedican
O. Ganz
N. Surprise
R. O. Meyers
Christian M. Capitini
Jacques Galipeau
Keywords:
Multiple myeloma
CD38
Ex vivo
T cell
Cancer research
Peripheral blood mononuclear cell
combination immunotherapy
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]